Skip to content
PARTICIPER À UNE ÉTUDE
LISTE DE DIFFUSION
X page opens in new window
AB SCIENCE
Discipline serving the patients
Home
Company
Corporate Overview
Executive Commitee
Scientific Committee
Values
Science
Overview
Masitinib in sickle cell disease
Masitinib in neurodegenerative disorders
AB8939 in oncology
Publications
Pipeline
Pipeline Overview
Masitinib
Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Sickle Cell Disease
Alzheimer’s Disease
AB8939
News and Media
Press releases
In the Media
Webcasts
Investors
Why invest in AB Science
Investor Kit
Regulated information
Annual reports
Half-year reports
Social and environmental responsabilities
Shareholders General Meeting
Outstanding shares and voting rights
Regulated agreements
Articles of Incorporation
Board of Directors Charter
Information document
Stock Information
General Information
Analyst Coverage
Financial Calendar
Masivet®
About Masivet®
Medical information and Pharmacovigilance
Careers
Contact
EN
Search:
Home
Company
Corporate Overview
Executive Commitee
Scientific Committee
Values
Science
Overview
Masitinib in sickle cell disease
Masitinib in neurodegenerative disorders
AB8939 in oncology
Publications
Pipeline
Pipeline Overview
Masitinib
Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Sickle Cell Disease
Alzheimer’s Disease
AB8939
News and Media
Press releases
In the Media
Webcasts
Investors
Why invest in AB Science
Investor Kit
Regulated information
Annual reports
Half-year reports
Social and environmental responsabilities
Shareholders General Meeting
Outstanding shares and voting rights
Regulated agreements
Articles of Incorporation
Board of Directors Charter
Information document
Stock Information
General Information
Analyst Coverage
Financial Calendar
Masivet®
About Masivet®
Medical information and Pharmacovigilance
Careers
Contact
La version française du site d’AB Science sera mise en ligne très prochainement.
Partager cette page
Share on LinkedIn
Share on LinkedIn
Share on X
Share on X
Share on Facebook
Share on Facebook
Share on WhatsApp
Share on WhatsApp
Pin it
Share on Pinterest
Go to Top
